Categories: Venture Capital

Teralys Capital closes oversubscribed $375 million Innovation Fund

Montreal’s Teralys Capital has announced the final closing of its significantly oversubscribed $375 million Teralys Capital Innovation Fund, positioning it as Canada’s largest innovation-focused private investment fund, managing over $1.6 billion in venture capital.
This fund of funds was created under the Government of Canada’s Venture Capital Action Plan (VCAP) in collaboration with the Government of Quebec, as well as several other institutional investors, both Canadian and international, including the Caisse de dépôt et placement du Québec, Fonds de solidarité FTQ, Investissement Québec, BDC Capital, Fondaction CSN, Fiera Capital, Lune Rouge, Bpifrance, National Bank of Canada, La Capitale, Desjardins Group and Consensus Business Group.
“Teralys Capital’s newest investment vehicle builds on the very same guiding principles at the core of our mission: (i) fostering the development of high potential innovative businesses across Canada; (ii) enabling profitable local economic development and job creation; (iii) while generating superior financial returns for all stakeholders”, said Éric Legault, Managing Partner at Teralys Capital.
With in-house technical experts specializing in information technologies, life sciences, and clean or industrial innovations, the Teralys Capital Innovation Fund will cover investments ranging from start-up and seed funding to helping companies expand and grow to technology buy-outs, having already completed 10 new fund investments and five direct investment in Canadian companies, including Zymeworks, Lightspeed, eSentire and Luxury Retreats.
Teralys has also played a leadership role with venture capital managers, including Georgian Partners, iNovia Capital, McRock Capital, Information Venture Partners, White Star Capital, Persistence Capital Partners, Sofinnova Capital, Clarus Lifesciences and OpenText Enterprise Application Fund.
“Innovation and support to entrepreneurs drive all our actions at Teralys Capital”, said Jacques Bernier, Managing Partner at Teralys Capital. “The Fund intends to seek top tier financial returns by structuring investments in private venture capital funds specialized in innovation. On a long-term basis, these investments will support a profitable and globally competitive venture capital industry, and will allow skilled managers to emerge and to attract the funds required to accelerate the growth and success of our best innovation-driven entrepreneurs.”

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: teralys capital
Terry Dawes

Recent Posts

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

16 hours ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

17 hours ago

Is GOOGL still a buy?

Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]

2 days ago

NLH has 173% upside, Echelon says

Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his "Buy" rating on Nova Leap Health (Nova Leap… [Read More]

2 days ago

Shopify upgraded to “Buy” at Citi

The stock has been flat since November, but Citi analyst Tyler Radke thinks there is now money to be made… [Read More]

2 days ago

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

4 days ago